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Letter to the Editor
Re: Luke Harper, T. Blanc, M. Peycelon, et al. Circumcision
and Risk of Febrile Urinary Tract Infection in Boys with
Posterior Urethral Valves: Result of the CIRCUP
Randomized Trial. Eur Urol. In press. https://doi.org/
10.1016/j.eururo.2021.08.024
We wish to congratulate Dr. Sauvat’s team for undertaking a
randomized controlled trial looking at the role of circumcision in decreasing the risk of febrile urinary tract infections
(UTIs) in boys with posterior urethral valve (PUV) [1]. At 2
yr, the risk of febrile UTI was 3% among boys undergoing
circumcision (+ antibiotic prophylaxis), compared to 20%
for the group receiving antibiotics alone, translating to a
tenfold risk reduction and a number needed to treat of six.
This effect was amplified further when a less stringent
(and arguably more clinically relevant) definition of UTI
was used. In addition, protocol-mandated scintigraphy also
suggested a potential benefit in reducing renal scarring in
the circumcision group. We would like some clarification
for certain issues and highlight some pertinent points.
1. The authors do not clearly specify if undergoing primary
valve ablation was an inclusion criterion or if boys undergoing vesicostomy/supravesical diversion were also included.
One of the more interesting aspects was the presence of
dilating (grade 3–5) vesicoureteral reflux (VUR) in more than
half of all boys (62% in the antibiotic only group vs 50% in
the circumcision + antibiotic group). The beneficial impact of
circumcision would be even greater in PUV cases with VUR
given their high propensity for febrile UTIs (at least until
VUR resolves, which was >50% in the study), so the overall
effect size in this study may in fact have been diluted by
inclusion of non-VUR patients.
2. The authors state that it is usual practice in their country for
all newborn boys with PUV to be on antibiotic prophylaxis
(regardless of the presence of VUR), while starting anticholinergic treatment is not. A prior randomized study
showed the efficacy of oxybutynin (0.2 mg/kg three times
daily) in aiding resolution of hydronephrosis and VUR over
1-yr follow-up [2], although it did not significantly decrease
risk of febrile UTI (30% vs 40%). The latter finding may be
related to the small absolute numbers, discontinuation of
oxybutynin (20%), or lack of routine circumcision or antibiotic prophylaxis in the study. It is unclear in the current
study whether any patients received anticholinergic therapy
and the potential impact on UTI.

3. As the authors point out, most of the febrile UTIs happened
over the first year of follow up. The febrile UTI incidence of
20% despite continuous antibiotic prophylaxis (control
arm) remains a cause for concern. It would be interesting
to see the resistance patterns for patients who had febrile
UTIs or antibiograms from the authors’ institution/region,
especially given the rising resistance of uropathogens to
extended-spectrum penicillin and first- and second-generation cephalosporins among children with congenital anomalies of the kidney and urinary tract [3].

In summary, this was a very well-conducted study providing objective evidence for what was generally believed
to be intuitively true. We posit that children with PUV
and dilating VUR/hydronephrosis are at the greatest risk
of UTI. Given the emergence of resistant organisms, future
studies assessing the benefit of circumcision, with or without anticholinergic or a-blocker therapy, may determine if
there are groups for which prophylaxis can be eliminated.
Conflicts of interest: The authors have nothing to disclose.
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